Compare MMLP & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMLP | SEER |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.1M | 97.3M |
| IPO Year | 2002 | 2020 |
| Metric | MMLP | SEER |
|---|---|---|
| Price | $2.44 | $2.22 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 10.4K | ★ 1.8M |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,653,009,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.65 | ★ 16.99 |
| 52 Week Low | $1.89 | $1.55 |
| 52 Week High | $3.54 | $2.41 |
| Indicator | MMLP | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 57.95 | 62.77 |
| Support Level | $2.51 | $1.85 |
| Resistance Level | $2.77 | $2.37 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 100.00 | 93.02 |
Martin Midstream Partners LP has a diverse set of operations focused on the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products, including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing, and distribution; and natural gas liquids marketing, distribution and transportation services. The company operates in four segment Terminalling and storage, Transportation, Sulfur service, and Specialty products segment. The majority of the revenue is derived from the Specialty products segment.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.